Meeting the demand for potent product handling in a sterile environment
Active Pharmaceutical Ingredients (API) are generally becoming more potent, with occupational exposure limits (OEL) of 1µg/m3 now being considered the…
In association with ILC Dover
Powder Handling
Latest in
Powder Handling
How containment systems impact productivity and profitability for HPAPI development
The pharmaceutical industry continues to bring us new and exciting innovations. Advancements in clinical pharmacology and oncology research have changed…
The DoverPac story: what increased HPAPI usage means for containment systems
The rising use of high-potency active pharmaceutical ingredients (HPAPIs) in drug development, driven largely by growing demand for targeted oncology…
Single-use isolation technology for safe handling of oxygen sensitive materials
ILC Dover’s recent webinar discussed the biopharma containment company’s range of specialised flexible isolator solutions designed for safe handling of…
Creating a disposable aseptic isolation system
Industry-leading provider of flexible containment solutions, ILC Dover, has released its new whitepaper: Development of a Disposable Grade-A Aseptic Fill/Finish…
Is a hooded PAPR right for your organisation?
In this day in age, it’s important for companies from every industry to have superior respiratory protection against a range…
The right transfer solutions for media and buffer powders
The pharmaceutical and biopharmaceutical industries are facing new challenges with powder handling on a scale that has never seen before.…
Flexible Isolator Technology: The Containment Solution for Pharmaceutical Processing
Over the past few decades, the pharmaceutical industry has been challenged with the introduction of hormones, steroids, and other cytotoxic…
How single-use FIBC containment systems can work for you
DoverPac® Containment Systems are the global standard for disposable process and powder containment systems. In 1997, ILC Dover worked in collaboration with Eli Lilly…
High containment for lyophilisation processes
The growth of lyophilisation and its complicated processes has challenged manufacturers to maintain safety for operators working with highly potent…
The benefits of single-use plastics versus reusable systems in upstream processes
For years pharmaceutical manufacturers have invested in rigid stainless steel equipment for upstream processing. While this traditional approach made sense…
To clean or not to clean? Why single use is better for pharma HPAPI containment
Pharmaceutical drug development is continually challenged to provide better compounds to treat a wide range of disease and illness. In…
How CMO/CDMO facilities can gain value with single use containment
The last few years have proven pivotal for contract manufacturing and development organisations (CMOs and CDMOs). With rapid development in…
HPAPI: Dealing with containment challenges
As a result of advances in clinical pharmacology and oncology research, highly potent active pharmaceutical ingredients (HPAPIs) have experienced a…
How “just in time” hydration of cell culture media can be optimised by single-use powder handling
Just in time manufacturing is a practice carried out across many industries, which aims to generate product as efficiently as…
Transforming preparation processes with the EZ BioPac transfer bag
Traditionally, media and buffer preparation has been carried out by transferring ingredients from stock containers using open scoops. It is…
ILC Dover’s new Cork manufacturing plant includes 10,500 sq ft of clean room capability
MEP Deirdre Clune officially opened the new ILC Dover manufacturing facility in Blarney Business Park, Cork alongside ILC Dover CEO…
What is biomanufacturing?
Biomanufacturing is a process of production which uses both natural and engineered biological systems, such as microorganisms and cell cultures,…
The environmental benefits of single-use pharmaceutical containment plastics
Implementing single-use powder-handling technologies in the pharmaceutical workplace can drastically improve a production line’s efficiency as it reduces or eliminates…
Learn how the innovations from Space Suits are applied in modern drug manufacturing
In 1961 John F. Kennedy announces to congress that the United States would embark on a mission to put “man…
The challenges of scaling up pharmaceutical manufacturing
Maintaining the integrity of a drug during a pharmaceutical manufacturing scale-up isn’t always an easy feat, but it’s essential for…
ILC Dover’s JetMixer: an efficient method of liquefying powders
Hydrating a range of powders efficiently and without contamination in an ever-increasing volume is an essential operation of biopharmaceutical manufacturing. …
How to prevent contamination in a biopharmaceutical manufacturing operation
Unlike traditional pharmaceuticals, biopharmaceuticals are a result of the genetic manipulation of living cells. Developing these extremely complex structures comes…
Should pharmaceutical manufacturers invest in single-use containment?
In an industry where safety is of the utmost importance ILC Dover’s single-use systems offer some of the most advanced…
Flexible powder containment: ILC Dover’s DoverPac system
DoverPac is a flexible containment system developed by engineering development and manufacturing company ILC Dover in collaboration with global pharmaceutical…
Effective containment systems for high potency active pharmaceutical ingredients (HP APIs)
The rules and regulations that pharmaceutical manufacturers must follow largely vary between regulatory agencies. However, there is one thing that…
Reduce cross-contamination risk with single-use isolator technology
The current trend of increasing potency of drug substances is driving the need for better cleaning methods to reduce cross-contamination.…
How CMOs can benefit from single-use solutions
Pharmaceutical companies are increasingly turning to contract manufacturing organisations (CMOs) to make their products, which frees up more time and…
The high cost of contamination in drugs manufacturing
Pharmaceuticals is one of the highest value industries globally, with 28 of the 1,000 largest companies in the world by…
How safe is your process? The usual causes of pharmaceutical contamination
Large-scale plant shutdowns are somewhat rare in the pharmaceutical industry, given the high level of care that manufacturers must take…
ILC Dover flexible isolators: A cost-effective way to maximise containment
High potency active pharmaceutical ingredients (HP APIs) are the fastest growing segment of the API market. This is mainly due…
Powder containment experts: Interview with ILC Dover chief executive Fran DiNuzzo
USA-based ILC Dover are world leaders in the production of high-performance flexible materials and acknowledged as powder containment experts when…
What is powder containment and why is it vital for the pharmaceutical industry?
Powder containment is the process of safely containing potentially dangerous substances, including powders, dust or vapours, during the manufacturing of…
Safe powder containment: Why EZ BioPac from ILC Dover is reducing risk
EZ BioPac is a cutting-edge powder containment and transfer system which maximises efficiency and provides safe powder containment for drugs…
Continuous liner systems ensure the safe transfer of pharmaceutical ingredients
Continuous liner systems is an effective way to contain and transfer hazardous ingredients and materials, ensuring the safe movement of…